Member Info for jezza1977

A single serious reaction to car t treatment in the first cohort - as referenced by aldebaran - highlights how good hgct1 really is. this top level safety profile is the reason why hgct1 looks like the real deal - as it attacks cancer cells hard and leaves most of the healthy FLT3 expressing cells. people need to understand this point.

just read haywains explanation on the sharediver site which goes into proper scientific detail. you might want to copy and paste that over Lostapound for all to read.

good luck fellow investors.

"And those profits increased while Hemo shareprice flops"

so you a shorter. the small credibility you had just evaporated. all makes sense now.

Hemo on track i hear from the AGM - good enough for me. no problems, plenty of funding, hemo happy.

i think once they have got the 'first run' challenges done again like

-new manufacturer

-larger batch of CAR T for adults

-child recruitment/profiling etc

hemo can move rapidly through the remaining cohort. but we shall see. oddly to most im sure but i remain excited for some powerful news and northward sp movements.

Avacta have better mgmt and better comms. so could be said they are maximising their potential currently. no areas for improvement because their comms are so good? hemo has been silence for 9 months resulting in where we are now. people desperate for updates. the only way is up one could say. in horse racing terms:-

AVACTA - EXPOSED

HEMO - UNEXPOSED

much bigger short term potential for large SP shifts at hemo imo.

imo.

If success was measured on the number of RNSs released Avacta are certainly the boss.

DSMB sign off v Alde whims…

You talk in generalisations. this is HEMO. we know three patients have passed safety comfortably. id suggest that would be very encouraging to anyone suffering with something as serious r/r AML.

but ok.

You talk in generalisations. this is HEMO. we know three patients have passed safety comfortably. id suggest that would be very encouraging to anyone suffering with something as serious r/r AML.

but ok.

Losta, you do know most patients with r/r AML are dying pretty soon? i do not see how any sufferer would turn down a new treatment and a chance to save their lives!?!? an odd thing to say imo.

News is either ready for announcement or it isn’t. Much of HEMOs work streams rely on third parties so there are a lot of things are out of Vlads hands right now. we need others to pull their fingers out.

the AGM is low on my list of priorities of things I want to see or hear. trial recommencement, Estonia, CDX and CBR are the important things to me.

Some quiet while we wait is pleasant.

Give me strength... not sure this is any more sensible that 141s posts.

"A little worry for me is that potential patients ask about outcomes to date and are told: "The lymphodepleting chemo is potent and the survival after infusion is X" and they think: "That doesn't sound worth it"."

You are proven to be wrong 141, its not complicated to understand anything with a 1 in front of it is part of phase 1 and covered in the costs. no more replies to you from me troll.

So you agree phase 1b is not part of phase 2. Which means its part of phase 1. which means costs are covered. thanks for confirming you agree 141.

Mrjinx, they have 4 staff. monthly fixed costs have been cut massively. manufacturing is the cost drain for the trial and if we're not manufacturing then they're not spending much. Thats how i see it. And the cost of manufacturing through Made has also been cut massively.

141, is phase '1b' as you put it part of phase 1 or phase 2?

Mrjinx, they have 4 staff. monthly fixed costs have been cut massively. manufacturing is the cost drain for the trial and if we're not manufacturing then they're not spending much. Thats how i see it. And the cost of manufacturing through Made has also been cut massively.

141, is phase '1b' as you put it part of phase 1 or phase 2?

From the chairman's statement in the year end report. for clarity.

"... £2.5 million after the year end. This financing in itself would take us through and beyond the next phase of our Phase 1 trials, which involves the treatment of a further three patients with an escalated dose. In addition, we have just announced the raise of a further equity raise of £3 million, which we believe will be sufficient to allow us to take the full Phase 1 trials to completion."

141 is a parody account - has to be.

The excitement finally begins to grow - its nice to the SP creeping up a bit. looking forward to hearng the trials properly restarted and p4 has got dosed. i think it will go adult first then a kid but we will see.

Awaiting FDA to approve hgct1 before Estonia will move? I spat my tea out.